Skip Navigation LinksHome > October 2013 - Volume 19 - Issue 11 > The Epidemiology of Anemia in Pediatric Inflammatory Bowel D...
Inflammatory Bowel Diseases:
doi: 10.1097/MIB.0b013e31829ed855
Original Clinical Articles

The Epidemiology of Anemia in Pediatric Inflammatory Bowel Disease: Prevalence and Associated Factors at Diagnosis and Follow-up and the Impact of Exclusive Enteral Nutrition

Gerasimidis, Konstantinos PhD*; Barclay, Andrew MD; Papangelou, Alexandros MSc*; Missiou, Despoina MSc*; Buchanan, Elaine BSc; Tracey, Cardigan BSc; Tayler, Rachel MB, ChB; Russell, Richard K. PhD; Edwards, Christine A. PhD*; McGrogan, Paraic MB, ChB

Supplemental Author Material
Collapse Box

Abstract

Background:

Anemia is poorly studied in pediatric inflammatory bowel disease. This study explored the epidemiology and associated factors of anemia at diagnosis, after 1 year, and during treatment with exclusive enteral nutrition (EEN).

Methods:

Three cohorts were included: (1) a representative population of newly diagnosed inflammatory bowel disease children (n = 184); (2) patients currently receiving care with data available at diagnosis (n = 179) and after 1 year (n = 139); and (3) 84 children treated with EEN.

Results:

At diagnosis, 72% were anemic. Abnormal inflammatory markers were more common in Crohn’s disease with severe anemia (severe versus no anemia [%]: raised C-reactive protein; 89% versus 48%; suboptimal albumin; 97% versus 29%; P < 0.002). Anemic children with Crohn’s disease had shorter diagnosis delay and lower BMI than nonanemic patients (severe versus mild versus no anemia, median [interquartile range]; diagnosis delay [months]: 3 [3.9] versus 6 [10] versus 8 [18], P < 0.001; BMI z score [SD]: −1.4 [1.4] versus −1.3 [1.5] versus −0.2 [1.4], P = 0.003). Extensive colitis was associated with severe anemia in ulcerative colitis. The proportion of severely anemic patients decreased from 34% to 9% and mild anemia doubled at 1 year. After EEN, severe anemia decreased (32% to 9%; P < 0.001) and the hemoglobin concentration increased by 0.75 g/dL. This was observed only after 8 weeks of treatment. Disease improvement and low hemoglobin at EEN initiation but not weight gain were associated with hemoglobin improvement.

Conclusions:

Anemia is high at diagnosis and follow-up and should receive more attention from the clinical team; however, the focus should remain suppression of inflammatory process in active disease.

Copyright © 2013 Crohn's & Colitis Foundation of America, Inc.

You currently do not have access to this article.

You may need to:

Note: If your society membership provides for full-access to this article, you may need to login on your society’s web site first.

Login

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.